LAZCLUZE

LAZERTINIB · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LAZCLUZE, covering 2024-08-19 to 2026-03-26. Get the full timeline:

Most recent: EMA Authorised: Lazcluze (lazertinib mesilate monohydrate) — Janssen Cilag International NV